Quipt Home Medical

QIPT

Market cap $158M

MILWAUKEE , Dec. 16, 2025 /PRNewswire/ -- The Ademi Firm is investigating Quipt (Nasdaq: QIPT) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Kingswood and Forager. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995.

NEW YORK , Dec. 15, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Quipt Home Medical Corp. (NASDAQ: QIPT) related to its sale to affiliates of Kingswood Capital Management, LP.

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Quipt Home Medical Corp. (NASDAQ: QIPT) to affiliates of Kingswood Capital Management, L.P. and Forager Capital Management, LLC for $3.65 per share is fair to Quipt shareholders. Halper Sadeh encourages Quipt shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpe.

HOUSTON--(BUSINESS WIRE)--Bradley L. Radoff, who collectively with his affiliates owns approximately 4.9% of the outstanding common shares of Quipt Home Medical Corp. (NYSE: QIPT) ("Quipt" or the "Company"), today issued the following statement regarding the manner in which the Company's Board of Directors (the “Board”) has failed to capitalize on apparent acquirer interest: “The Board has spent years destroying its credibility by presiding over poor execution and significant shareholder value.

CHICAGO--(BUSINESS WIRE)--Lakeview Opportunity Fund, LLC (together with its affiliates, “we” or “Lakeview Investment Group”), a nearly 5% owner, and top 5 shareholder of Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ: QIPT and TSX: QIPT), today expressed its belief that the Company's Board of Directors (the “Board”) has undermined the best interests of shareholders by failing to engage in good faith with a credible bidder as part of a transparent and viable strategic review. Rather.

Quipt Home Medical (QIPT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Transaction Strengthens Health System Partnerships, Expands Midwest Footprint, and Reinforces Long-Term Growth Strategy Transaction Strengthens Health System Partnerships, Expands Midwest Footprint, and Reinforces Long-Term Growth Strategy

Quipt Home Medical Corp. (NASDAQ:QIPT ) Q3 2025 Earnings Conference Call August 12, 2025 10:00 AM ET Company Participants Gregory J. Crawford - Chairman, President & CEO Hardik Mehta - Chief Financial Officer Conference Call Participants Doug Cooper - Beacon Securities Limited, Research Division William Sutherland - The Benchmark Company, LLC, Research Division Operator Thank you for standing by.

Transaction Adds $60 Million in Revenue, 29 Locations, Deep Health System Relationships, and Marks Entry Into Michigan Market Transaction Adds $60 Million in Revenue, 29 Locations, Deep Health System Relationships, and Marks Entry Into Michigan Market

Posts Positive Organic Growth and Adjusted EBITDA ‎ 1 of 23.5% of Revenue